OUT-LICENSING IN MARKETS WITH ASYMMETRIC INFORMATION:: THE CASE OF THE PHARMACEUTICAL INDUSTRY.Published in:International Journal of Innovation Management, 2011, v. 15, n. 4, p. 755, doi. 10.1142/S1363919611003313By:REEPMEYER, GERRIT;GASSMANN, OLIVER;RÜTHER, FRAUKEPublication type:Article
Organizing Pharmaceutical Innovation: From Science-based Knowledge Creators to Drug-oriented Knowledge Brokers.Published in:Creativity & Innovation Management, 2005, v. 14, n. 3, p. 233, doi. 10.1111/j.1467-8691.2005.00344.xBy:Gassmann, Oliver;Reepmeyer, GerritPublication type:Article